Studies have shown that the binding activity between CD44 and hyaluronic acid is notably enhanced after sialic acid molecules of the N-glycosylation chain on CD44 are specifically removed by treating HCC cells with sialidase NEU4, which inhibits the migration of HCC cells [56]. Here, CD44 is linked to hepatocellular carcinoma.